Considering that binding of both OC125 and M11 is required for the generation of a signal in the clinical immunoassay, this differential binding pattern may present a mechanism of undercounting MUC16 present in the serum of ovarian cancer patients. The gene discussed is MUC16; the disease is ovarian carcinoma.